Keyphrases
Infective Endocarditis
68%
Biofilm
60%
Pseudomonas Aeruginosa Biofilm
56%
Hyperbaric Oxygen Therapy
55%
Staphylococcus Aureus
45%
Antibiotics
42%
Biofilm Infection
39%
S100A8
36%
Tobramycin
36%
Pseudomonas Aeruginosa (P. aeruginosa)
36%
Staphylococcus Aureus Endocarditis
32%
Host Response
28%
Ciprofloxacin
25%
Post-infection
23%
Simulation Model
21%
Improved Outcomes
21%
Chronic Wounds
18%
Neutrophils
16%
Bacterial Biofilm
15%
New Treatment Options
14%
Wound Healing
14%
Antibiotic Treatment
14%
Delayed Closure
13%
Immune Regulation
13%
Quantitative Bacteriology
12%
Balb C Mice
12%
Left-sided Infective Endocarditis
12%
Cystic Fibrosis
12%
Vascular Endothelial Growth Factor
11%
GLS2
10%
Innate Resistance
10%
Complicating Factors
10%
Azithromycin
10%
Lipocalin 2 (LCN2)
10%
Matrix Gene
10%
Antibiotic Levels
10%
Staphylococcus Aureus Bacteremia
10%
Pulmonary Infection
10%
HOX Transcript Antisense RNA (HOTAIR)
10%
Human Neutrophils
10%
Mycobacterium Tuberculosis (M. tb)
10%
Genetic Drift
10%
Dabigatran
10%
Personalized Medicine
10%
Microcompartment
10%
Antibiofilm
10%
Negative Test Results
10%
Chronic Wound Model
10%
Probability of Target Attainment
10%
Neutrophil Activation
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas aeruginosa
65%
Bacterial Endocarditis
60%
Infection
59%
Antibiotics
36%
Staphylococcus Aureus
36%
Endocarditis
32%
Antibiotic Agent
32%
Chronic Wound
29%
Tobramycin
25%
Wound
24%
Cytokine
18%
Mouse
18%
Antibiotic Therapy
15%
Ciprofloxacin
14%
Wound Healing
14%
Wound Infection
11%
Pharmacokinetics
11%
Bird
10%
Growth Factor
10%
Azithromycin
10%
Influenza A Virus (H3N2)
10%
Lung Infection
10%
Immunoglobulin Y
10%
Dabigatran
10%
Bagg Albino Mouse
10%
Cystic Fibrosis
8%
Vasculotropin
8%
Pharmacodynamics
8%
C3H/He Mouse
8%
Burn
6%
Inflammation
6%
Keratinocyte Derived Chemokine
5%
Foreign Body
5%
Pseudomonas
5%
Influenza A
5%
Infectious Agent
5%
Disease
5%
Immunology and Microbiology
Biofilm
100%
Endocarditis
77%
Staphylococcus Aureus
68%
Pseudomonas aeruginosa
65%
Immune Response
28%
Neutrophil
24%
Cytokine
20%
Bacteriology
19%
Mouse
18%
Bacterial Load
13%
Genetic Variation
10%
Dynamics
10%
Genetic Drift
10%
Lipocalin-2
10%
Mycobacterium Tuberculosis
10%
Influenza A Virus (H3N2)
10%
Immunoglobulin Y
10%
Bird
10%
Granulocyte
10%
Bactericidal Activity
9%
Aortic Valve
9%
Influenza
8%
Neutrophil Granulocyte
7%
Keratinocyte Derived Chemokine
7%
Heart Valve
7%
Pseudomonas
6%
Infectious Agent
5%
Penicillin
5%
Minimum Inhibitory Concentration
5%
Rat Model
5%
Host Resistance
5%
Bagg Albino Mouse
5%
